BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26384602)

  • 1. Improved harmonization of eosin-5-maleimide binding test across different instruments and age groups.
    Agarwal AM; Liew MA; Nussenzveig RH; Sangle N; Heikal N; Yaish H; Christensen R
    Cytometry B Clin Cytom; 2016 Nov; 90(6):512-516. PubMed ID: 26384602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
    Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
    Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
    Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
    Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
    Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
    Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
    Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins.
    King MJ; Jepson MA; Guest A; Mushens R
    Int J Lab Hematol; 2011 Apr; 33(2):205-11. PubMed ID: 21054813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
    Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis.
    Shahal-Zimra Y; Nosgorodcky Y; Eshel E; Rotem Z; Ross L; Pickholtz I; Rabizadeh E; Chezar J
    Cytometry B Clin Cytom; 2022 Sep; 102(5):377-383. PubMed ID: 34528390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
    Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
    Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.
    Watanabe T; Ono H; Tajima I; Ishigaki H; Hakamata A; Shirai M; Endoh A; Hongo T
    Pediatr Int; 2014 Jun; 56(3):427-9. PubMed ID: 24894931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
    Trabelsi N; Bouguerra G; Haddad F; Ouederni M; Darragi I; Boudrigua I; Chaouachi D; Barmat M; Fouzai C; Bejaoui M; Menif S; Kraiem I; Abbes S
    Cell Physiol Biochem; 2021 Mar; 55(1):117-129. PubMed ID: 33667330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
    Andres O; Eber S; Speer CP
    Ann Hematol; 2015 Dec; 94(12):1959-64. PubMed ID: 26336967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
    Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
    Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosin-5'-maleimide binding test-Do we use appropriate reference values to detect hereditary spherocytosis in neonates?
    Ciepiela O; Nowak M; Wrońska M; Adamowicz-Salach A; Kotuła I
    Int J Lab Hematol; 2019 Jun; 41(3):e57-e60. PubMed ID: 30548189
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
    Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
    J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells.
    Suemori S; Wada H; Nakanishi H; Tsujioka T; Sugihara T; Tohyama K
    Biomed Res Int; 2015; 2015():451861. PubMed ID: 26557672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow-assisted differential diagnosis of hemolytic anemia with spherocytosis: a case report].
    Won DI
    Korean J Lab Med; 2010 Aug; 30(4):339-44. PubMed ID: 20805704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.
    King MJ; Smythe JS; Mushens R
    Br J Haematol; 2004 Jan; 124(1):106-13. PubMed ID: 14675415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.